TCF7L2 Genotype and α-Cell Function in Humans Without Diabetes

Area of Science:

• Genetics
• Metabolic Disease
• Endocrinology

Background:

• The TCF7L2 gene is strongly associated with type 2 diabetes risk.
• The precise mechanism by which the diabetes-associated allele of TCF7L2 influences diabetes development remains unclear.

Purpose of the Study:

• To investigate if the TCF7L2 diabetes-associated allele (rs7903146) impairs insulin secretion.
• To determine if this impairment is exacerbated by acute free fatty acid (FFA)-induced insulin resistance.

Main Methods:

• Studied 120 individuals, comparing those homozygous for the risk allele (TT) with those homozygous for the protective allele (CC) at rs7903146.
• Utilized an oral glucose challenge with and without elevated free fatty acids (FFA) induced by Intralipid infusion.
• Assessed beta-cell responsivity using the oral C-peptide minimal model and measured glucagon suppression.

Main Results:

• Individuals with the TT genotype showed slightly impaired beta-cell responsivity compared to the CC genotype.
• A significant difference in the relationship between insulin secretion and beta-cell responsivity was observed between genotypes.
• The TT genotype group exhibited impaired suppression of glucagon following an oral glucose challenge.

Conclusions:

• A genetic variant in TCF7L2 (rs7903146) negatively impacts glucose tolerance.
• This TCF7L2 variant affects both insulin secretion and glucagon suppression, contributing to diabetes risk.
• The findings highlight the role of TCF7L2 in beta-cell function and glucose homeostasis.